Partners
Expanding Our Operations Globally
Bioventure has built a portfolio of products from different pharmaceutical domains including biosimilars, peptides, complex generics and innovations.
Bioventure is the leading regional entity with 13 biosimilars in its portfolio, and the leading local entity to handle biosimilar monoclonal antibodies in the UAE.
Bioventure has a clear strategic vision to drive short, medium and long-term growth through:
Established With A Mandate To Drive
Bioventure’s recent successful partnerships with Alvotech and Adalvo demonstrate our approach to commercialization across the Middle East and Africa.
Bioventure was established to promote innovation, business development and availability of value-added healthcare solutions globally.
Equity stake in Alvotech.
Exclusive partner for commercialization of Alvotech’s biosimilar portfolio across the Middle East and Africa.
Exclusive partnership for commercialization of select speciality generic products in licensed from Adalvo across the Middle East and Africa region.
X-Ray Imaging
Gynecology
Parenting
Consultations
We Are Trusted For Expertise and Care
Proactively envisioned multimedia based expertise and cross-media growth strategies. Seamlessly visualize quality intellectual capital without superior collaboration and pontificate installed base portals after maintainable products.
Distinctively exploit optimal alignments for intuitive bandwidth. Quickly coordinate e-business applications through revolutionary catalysts for change. Seamlessly optimal testing procedures whereas outside the box thinking.
Consult Our Doctors
Select the doctor you prefer to get a checkup and book a visit with them in a matter of minutes. Simply select from the list below.
